-
Cholesterol and the LNP Compartment Problem
2026-09-25
Cholesterol influences both membrane biology and lipid nanoparticle design, but those roles are not interchangeable. This article traces the compartments involved in intravesical p21 mRNA delivery and clarifies what the bladder cancer study does—and does not—show about cholesterol.
-
Phagocytic Giant Cancer Macrophages in Blood
2026-09-24
A two-year, multi-institutional prospective study examined circulating cancer-associated macrophage-like cells (CAMLs), described as phagocytic polyploid giant cancer cells, across six solid tumor types. The findings associate CAMLs with disease progression and spread and identify unusual proliferative and lineage-associated traits, supporting further evaluation as a blood-based research marker rather than establishing a standalone clinical test.
-
pH-Responsive cRGD-PEG-siRNA for Glioblastoma
2026-09-24
Su et al. developed a pH-responsive cRGD-PEG-siEGFR conjugate intended to improve tumor targeting and circulation while reducing renal accumulation compared with an earlier cRGD-siRNA construct. The study reports uptake and EGFR silencing in αvβ3-positive U87MG cells, alongside antitumor activity and favorable biodistribution findings; it supports further investigation of targeted siRNA delivery, not a clinical efficacy claim.
-
Dantrolene Sodium Salt in Calcium Signaling Research
2026-09-23
Use Dantrolene sodium salt to test whether ryanodine receptor–dependent calcium release contributes to disease-relevant cellular phenotypes, with practical guidance for dosing, controls, and troubleshooting. The article also puts recent CRISPR repair-pathway screening in context—an assay-design opportunity, not evidence that dantrolene itself changes DNA repair.
-
Verapamil, Txnip, and Osteoporosis: Study Analysis
2026-09-23
The reference study identifies TXNIP as a genetic and mechanistic link between verapamil exposure and osteoporosis biology. Using human genotype data, osteoclast and osteoblast assays, and an ovariectomy mouse model, the authors show that verapamil suppresses Txnip-associated bone turnover through ChREBP, PPARγ–MAPK/NF-κB, and ChREBP–Bmp2 signaling.
-
DNA Cleanup as Translational Risk Control
2026-09-22
Reliable translational biology begins with controlling preanalytical variables. This thought-leadership article explains how cation-dependent DNase I activity can be strategically deployed for RNA workflows, chromatin studies, and human-cell research, while using evidence from a human DRG study to show why sample integrity and orthogonal validation matter.
-
Ciprofloxacin Hydrochloride Research Workflows
2026-09-22
Turn Ciprofloxacin hydrochloride into a quantitative tool for growth inhibition, DNA-damage profiling, and antibiotic-combination studies. This guide emphasizes single-cell measurements, nutrient-aware interpretation, solution handling, and troubleshooting beyond a conventional bulk growth assay.
-
MK-1775 Workflow for Wee1 Checkpoint Studies
2026-09-21
Build more informative Wee1 inhibitor experiments by separating checkpoint abrogation, growth suppression, and actual cell killing. This workflow uses MK-1775 with orthogonal timing, viability, and DNA-damage readouts to improve combination studies in p53-deficient cancer models.
-
Protoporphyrin IX: Heme, Light, and Ferroptosis
2026-09-21
Learn how to deploy Protoporphyrin IX as a heme-pathway reagent, photodynamic compound, and hypothesis-generating probe for iron-dependent cancer biology. This practical guide combines handling guidance, light-controlled assay design, ferroptosis readouts, and troubleshooting for reproducible translational workflows.
-
Protoporphyrin IX Workflows for Heme and Photodynamic Resear
2026-09-20
Build controlled assays around Protoporphyrin IX for heme formation, light-triggered biology, and mechanistic ferroptosis studies. This guide separates photodynamic effects from iron-handling pathways with practical formulation, illumination, and troubleshooting workflows.
-
EZH2 Inhibition in HPV-Associated Cervical Cancer
2026-09-19
A 2025 study evaluates EPZ6438 and ZLD1039 as EZH2 inhibitors in HPV-positive and HPV-negative cervical cancer models. The findings connect EZH2 suppression with reduced proliferation, apoptosis, G0/G1 arrest, decreased HPV16 E6/E7 expression, and restoration of p53, Rb, and epithelial markers, while identifying greater activity of EPZ6438 in HPV-positive cells.
-
DiscoveryProbe Immunology/Inflammation Compound Library
2026-09-18
Turn a curated 295-compound collection into multiparametric evidence for immune activation, suppression, proliferation, and toxicity. This PBMC flow-cytometry workflow links phenotypic inflammation screening with inflammation target validation and mechanism-focused follow-up.
-
Verapamil HCl: Applied Calcium Signaling Workflows
2026-09-18
Verapamil HCl is an L-type calcium channel blocker for dissecting calcium-dependent signaling, apoptosis, drug accumulation, and inflammation. This workflow-focused guide shows how to design myeloma combination assays, interpret transporter-related effects, and extend findings into an arthritis inflammation model without overclaiming mechanism.
-
HyperScript™ Reverse Transcriptase for RNA-to-cDNA
2026-09-17
HyperScript™ Reverse Transcriptase supports demanding RNA-to-cDNA workflows when secondary structure, long transcripts, or limited template abundance can compromise routine reverse transcription. Its thermal stability and reduced RNase H activity make it a practical choice for qPCR studies of adipose remodeling, including Netrin-1, PPARγ, and Wnt/β-catenin signaling.
-
C34: A TLR4 Inhibitor for Assay Translation
2026-09-17
C34 is a selective TLR4 inhibitor for dissecting LPS-driven inflammatory signaling in macrophages, enterocytes, and translational neuroinflammation models. This guide explains how to use C34 as a pathway-control reagent, interpret evidence from microglial studies, and distinguish target-level conclusions from broader anti-inflammatory effects.